cAMP signalling in insulin and glucagon secretion
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The “second messenger” archetype cAMP is one of the most important cellular signalling molecules with central functions including the regulation of insulin and glucagon secretion from the pancreatic β‐ and α‐cells, respectively. cAMP is generally considered as an amplifier of insulin secretion triggered by Ca 2+ elevation in the β‐cells. Both messengers are also positive modulators of glucagon release from α‐cells, but in this case cAMP may be the important regulator and Ca 2+ have a more permissive role. The actions of cAMP are mediated by protein kinase A (PKA) and the guanine nucleotide exchange factor Epac. The present review focuses on how cAMP is regulated by nutrients, hormones and neural factors in β‐ and α‐cells via adenylyl cyclase‐catalysed generation and phosphodiesterase‐mediated degradation. We will also discuss how PKA and Epac affect ion fluxes and the secretory machinery to transduce the stimulatory effects on insulin and glucagon secretion. Finally, we will briefly describe disturbances of the cAMP system associated with diabetes and how cAMP signalling can be targeted to normalize hypo‐ and hypersecretion of insulin and glucagon, respectively, in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Insulin granule dynamics in pancreatic beta cells
Rorsman, P., & Renstr�m, E. (2003) · Diabetologia · doi:10.1007/s00125-003-1153-1 · Cited by 844
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481 · cited 2×
“Closure of KATP channels may also be facilitated by Epac2,(95) which binds to the SUR1 subunit of the channel.(81) The”
BackgroundRenström, E., Eliasson, L., & Rorsman, P. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.105bl.x · Cited by 299 · cited 2×
“This conclusion is consistent with results from capacitance measurements of exocystosis.(80,89) The combination of PKA and Epac activators is more efficient than either activator alone.”
BackgroundResultAmmälä, C., Eliasson, L., Bokvist, K., Larsson, O., Ashcroft, F. M., & Rorsman, P. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019966 · Cited by 270
Increased melatonin signaling is a risk factor for type 2 diabetes
Tuomi, T., Nagorny, C. L. F., Singh, P., Bennet, H., Yu, Q., Alenkvist, I., Isomaa, B., Östman, B., Söderström, J., Pesonen, A.-K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.009 · Cited by 262
De Marinis, Y. Z., Salehi, A., Ward, C. E., Zhang, Q., Abdulkader, F., Bengtsson, M., Braha, O., Braun, M., Ramracheya, R., Amisten, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.007 · Cited by 257 · cited 4×
“inhibition and stimulation of glucagon secretion could be mimicked by low and high concentrations of AC-activating forskolin.(112) However, direct recordings of cAMP indicated that individual α-cells located within islets only rarely respond to GLP-1.”
BackgroundInfluentialSUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells
Eliasson, L., Ma, X., Renström, E., Barg, S., Berggren, P.-O., Galvanovskis, J., Gromada, J., Jing, X., Lundquist, I., Salehi, A., et al. (2003) · The Journal of General Physiology · doi:10.1085/jgp.20028707 · Cited by 257
Moens, K., Heimberg, H., Flamez, D., Huypens, P., Quartier, E., Ling, Z., Pipeleers, D., Gremlich, S., Thorens, B., & Schuit, F. (1996) · Diabetes · doi:10.2337/diab.45.2.257 · Cited by 250
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Cryer, P. E. (2012) · Endocrinology · doi:10.1210/en.2011-1499 · Cited by 242
Adriaenssens, A. E., Svendsen, B., Lam, B. Y. H., Yeo, G. S. H., Holst, J. J., Reimann, F., & Gribble, F. M. (2016) · Diabetologia · doi:10.1007/s00125-016-4033-1 · Cited by 223 · cited 1×
“However, ghrelin, which was previously thought to act on Gαi-coupled β-cell receptors was recently found to activate Gαi-signalling indirectly by stimulating somatostatin secretion.(57) Like the case for cAMP-elevating agonists, also those with lowering effect act by additional mechanisms.”
BackgroundTight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells.
Barg, S., Galvanovskis, J., Göpel, S. O., Rorsman, P., & Eliasson, L. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1500 · Cited by 209
Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification
Barg, S., Huang, P., Eliasson, L., Nelson, D. J., Obermüller, S., Rorsman, P., Thévenod, F., & Renström, E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.11.2145 · Cited by 194
Glucose-Induced Cyclic AMP Oscillations Regulate Pulsatile Insulin Secretion
Dyachok, O., Idevall-Hagren, O., Sågetorp, J., Tian, G., Wuttke, A., Arrieumerlou, C., Akusjärvi, G., Gylfe, E., & Tengholm, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.003 · Cited by 193
Self-citationGLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation
Shigeto, M., Ramracheya, R., Tarasov, A. I., Cha, C. Y., Chibalina, M. V., Hastoy, B., Philippaert, K., Reinbothe, T., Rorsman, N., Salehi, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81975 · Cited by 189 · cited 1×
“The GLP-1 receptor also appears to couple via Gαq to stimulate phospholipase C, which generates Ca-mobilizing inositol-1,4,5 trisphosphate (IP3) and protein kinase C (PKC)-activating diacylglycerol.(53) PKC in turn depolarizes the β-cells by activating Na influx through TRPM4 and TRPM5 channels to promote voltage-depe…”
BackgroundParadoxical Stimulation of Glucagon Secretion by High Glucose Concentrations
Salehi, A., Vieira, E., & Gylfe, E. (2006) · Diabetes · doi:10.2337/db06-0080 · Cited by 159
Self-citationGuo, J. H., Chen, H., Ruan, Y. C., Zhang, X. L., Zhang, X. H., Fok, K. L., Tsang, L. L., Yu, M. K., Huang, W. Q., Sun, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5420 · Cited by 157
Gheni, G., Ogura, M., Iwasaki, M., Yokoi, N., Minami, K., Nakayama, Y., Harada, K., Hastoy, B., Wu, X., Takahashi, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.030 · Cited by 156
Olsen, H. L., Theander, S., Bokvist, K., Buschard, K., Wollheim, C. B., & Gromada, J. (2005) · Endocrinology · doi:10.1210/en.2005-0800 · Cited by 156
Gromada, J., Høy, M., Buschard, K., Salehi, A., & Rorsman, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00519.x · Cited by 120
Liu, Y.-J., Vieira, E., & Gylfe, E. (2004) · Cell Calcium · doi:10.1016/j.ceca.2003.10.002 · Cited by 118
Self-citationRamos, L. S., Zippin, J. H., Kamenetsky, M., Buck, J., & Levin, L. R. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200810044 · Cited by 118
Gromada, J., Ding, W.-G., Barg, S., Renström, E., & Rorsman, P. (1997) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240050431 · Cited by 110 · cited 1×
“Although the cAMP effects on electrical activity and [Ca]i signalling contribute to the amplification of insulin secretion, the quantitatively most important effects are exerted on secretory granule trafficking and exocytosis.(93) Both PKA and Epac promote secretory granule mobility, which leads to accelerated repleni…”
BackgroundActivation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84 · cited 1×
“A similar example is a polymorphism leading to increased expression of the Gαi-coupled melatonin receptor 1b with reduced cAMP formation and insulin secretion,(46) but persistent activation of this receptor has also been implicated in improved β-cell function and survival in type 2 diabetes-related molecular stress.(1…”
BackgroundDzhura, I., Chepurny, O. G., Kelley, G. G., Leech, C. A., Roe, M. W., Dzhura, E., Afshari, P., Malik, S., Rindler, M. J., Xu, X., et al. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.198424 · Cited by 67 · cited 2×
“from the same laboratory instead favour IP3-gated Ca 2+ release secondary to the Epac/Rap1-mediated activation of phospholipase C-ε.(96)”
BackgroundHenquin, J.-C., & Nenquin, M. (2014) · Endocrinology · doi:10.1210/en.2014-1247 · Cited by 41
Fujimoto, W., Miki, T., Ogura, T., Zhang, M., Seino, Y., Satin, L. S., Nakaya, H., & Seino, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1306-y · Cited by 32 · cited 1×
“larization also via PKA-independent activation of the non-selective cation channel TRPM2,(97) and via activation of niflumic acid-sensitive Cl channels, supposedly involved in β-cell sensing of gradual changes of the glucose concentration.(98) The effects of cAMP on β-cell Ca signalling is not restricted to regulation…”
Background
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“180,181,183 187 Interactions with other pathways GLP-1 not only promotes the release of insulin but also enhances the response of pancreatic β -cells to insulin through the PI3K/Akt pathway, thereby improving insulin signal transduction and increasing the sensitivity of peripheral tissues to…”
BackgroundRamracheya, R., Chapman, C., Chibalina, M., Dou, H., Miranda, C., González, A., Moritoh, Y., Shigeto, M., Zhang, Q., Braun, M., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13852 · Cited by 128
Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes
Omar-Hmeadi, M., Lund, P.-E., Gandasi, N. R., Tengholm, A., & Barg, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15717-8 · Cited by 105
Self-citationNew progress in drugs treatment of diabetic kidney disease
Wang, J., Xiang, H., Lu, Y., Wu, T., & Ji, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111918 · Cited by 74
Gonçalves, D. A., Silveira, W. A., Manfredi, L. H., Graça, F. A., Armani, A., Bertaggia, E., O´Neill, B. T., Lautherbach, N., Machado, J., Nogara, L., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12395 · Cited by 56
“It is also to note that, unlike α-AR stimulation by catecholamines, β-AR stimulation in β-pancreatic cells strongly stimulates INS release in systemically infused humans13 and in locally infused canine pancreas.61 This effect is probably mediated by the activation of cAMP signalling, a well described second messenger…”
Metadata
- Authors
- Tengholm, A., & Gylfe, E.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2017-09
- Volume
- 19
- Issue
- S1
- Pages
- 42-53
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2610797963
- Cited by
- 220
- References
- 29
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.